7 unknown, 6 completed, 2 terminated, 1 recruiting. 16 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 16 | Unknown 7, Completed 6, Terminated 2, Recruiting 1 |
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Oral Ulcer: new trials by email Literature Review of Oral Ulcer trials Research Report on Oral Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Topical Rebamipide Versus Topical Betamethasone for Treatment of Oral Aphthous Ulcers Rebamipide mouthwash, Betamethasone mouthwash - Oral Aphthous Ulcers | Phase 2 | Recruiting | Cairo University | 46 | 2026-07-01 | 2026-10-06 |
| Mucoadhesive Film With/without Acmella Oleracea & Triamcinolone Acetonide for Aphthous Ulcers mucoadhesive film with Acmella oleracea extract, Triamcinolone Acetonide 0.1% Oromucosal Paste, mucoadhesive film without Acmella oleracea extract - Aphthous Stomatitis | Phase 2 | Unknown | Khon Kaen University | 72 | 2024-10-15 | 2024-10-02 |
| Study for the Prevention of Oral Mucositis (SPOM) Bocaliner, Benzydamine - Oral Mucositis | Phase 1 / Phase 2 | Unknown | E2Bio Life Sciences, LLC | 100 | 2022-04-15 | 2023-09-08 |
| Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. Dentoxol mouthrinse dosages - Epidermolysis Bullosa, Oral Ulcer | Phase 2 | Unknown | University of Chile | 100 | 2022-04-06 | 2022-04-14 |
| Using Tea-based Mouthwash Relieve Stomatitis and Oral Ulcers mouthwash with tea - Stomatitis | Phase 2 | Unknown | Chang Gung Memorial Hospital | 100 | 2021-08-26 | 2021-08-18 |
| Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. Clonidine HCl Mucoadhesive Buccal Tablet, Placebo Mucoadhesive Buccal Tablet - Chemoradiotherapy-Induced Severe Oral Mucositis | Phase 2 / Phase 3 | Terminated | Monopar Therapeutics | 190 | 2021-02-11 | 2023-05-31 |
| Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis use of basil extract gel in treatment of aphthus ulcer, muco adhesive placebo gel, no treatment - Oral Ulcer | Phase 2 | Unknown | Tanta University | 30 | 2021-01-01 | 2021-07-14 |
| Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology Ustekinumab - LAD1 | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 6 | 2018-07-02 | 2024-10-22 |
| Use of Topical NSAID to Reduce Pain in Oral Lichen Planus and Oral Lichenoid Lesions. Ibuprofen suspension 5mg/100ml, Placebos - Oral Lichen Planus, Oral Lichenoid Mucositis | Phase 2 / Phase 3 | Completed | University of Washington | 23 | 2018-04-29 | 2020-05-08 |
| Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus Miracle Mouthwash Plus Hydrocortisone, Prednisolone - Stomatitis, Oral Mucositis | Phase 2 | Completed | US Oncology Research | 104 | 2014-09-04 | 2022-12-01 |
| Tocilizumab for the Treatment of Behcet's Syndrome Tocilizumab - Behcet Syndrome | Phase 2 | Terminated | NYU Langone Health | 1 | 2012-09-01 | 2019-02-15 |
| Diet and Lifestyle Intervention Study in Postpartum Women in China Diet and Lifestyle Intervention in Chinese Postpartum Women - Puerperal Infection, Fever | Phase 2 / Phase 3 | Unknown | Huazhong University of Science and Technology | 1600 | 2009-06-01 | 2009-12-24 |
| Efficacy of 5% Chitosan Nanoparticle Paste in the Treatment of Recurrent Aphthous Stomatitis Triamcinolone Acetonide 0.1% Oral Paste, 5 wt.% Chitosan Nanoparticle Paste - Recurrent Aphthous Stomatitis, Oral Ulcers | Phase 2 | Completed | Kerman University of Medical Sciences | 30 | 2009-04-21 | 2026-07-14 |
| Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae Prednisolone, Colchicine - Oral Aphthae | Phase 2 | Unknown | Mashhad University of Medical Sciences | 30 | 2007-05-01 | 2008-07-29 |
| Safety and Efficacy of RK0202 in Oral Mucositis RK-0202 - Mouth Diseases, Mouth Ulcers | Phase 2 | Completed | RxKinetix | 110 | 2003-01-01 | 2007-01-15 |
| Thalidomide to Treat Oral Lesions in HIV-Infected Patients Thalidomide - Acquired Immunodeficiency Syndrome, Burning Mouth Syndrome | Phase 2 | Completed | National Institute of Dental and Craniofacial Research (NIDCR) | 110 | 1996-06-01 | 2008-03-04 |
Stomatitis (5) · Stomatitis, Aphthous (4) · Foot-and-Mouth Disease (2) · Head and Neck Neoplasms (2) · Mucositis (2) · Acquired Immunodeficiency Syndrome (1) · Anemia (1) · Behcet Syndrome (1) · Breast Diseases (1) · Breast Neoplasms (1) · Burning Mouth Syndrome (1) · Constipation (1) · Epidermolysis Bullosa (1) · Fever (1)
Stomatognathic Diseases (16) · Mouth Diseases (15) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Infections (4) · Stomatitis (4) · Digestive System Diseases (3) · Gastrointestinal Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · RNA Virus Infections (3) · Virus Diseases (3) · Animal Diseases (2) · Cardiovascular Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)
Anti-Inflammatory Agents (2) · Prednisolone (2) · Triamcinolone Acetonide (2) · Benzydamine (1) · Betamethasone (1) · Colchicine (1) · Diet (1) · Gramicidin, Neomycin Sulfate, Nystatin, Triamcinolone Acetonide Drug Combination (1) · Hydrocortisone (1) · Methylprednisolone (1) · Mouthwashes (1) · Multicenter Studies as Topic (1) · Ointments (1) · Suspensions (1) · Tea (1)
Cairo University (1) · Chang Gung Memorial Hospital (1) · E2Bio Life Sciences, LLC (1) · Huazhong University of Science and Technology (1) · Kerman University of Medical Sciences (1) · Khon Kaen University (1) · Mashhad University of Medical Sciences (1) · Monopar Therapeutics (1) · NYU Langone Health (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1) · RxKinetix (1) · Tanta University (1) · US Oncology Research (1) · University of Chile (1)
United States (7) · Egypt (2) · Armenia (1) · Canada (1) · Chile (1) · China (1) · France (1) · Germany (1) · Iran (1) · Puerto Rico (1) · Spain (1) · Taiwan (1)
Andy Trotti, MD (1) · Beatriz E Marciano, M.D. (1) · Donald Welsh, MD (1) · Doug Peterson, DMD (1) · Guy Juillard, MD (1) · Holli Carlson (1) · Jim Wright, MD (1) · John Feldmeier, DO (1) · Joyce A. O'Shaughnessy, MD (1) · Kemporn Kitsahawong, Ph.D (1) · Liegang Liu, PhD (1) · Mark Chambers, DMD MS (1) · Rufus Scrimger, MD (1) · Samy El Sayed, MD (1) · Steve Sonis, DMD DMSc (1)
PMID 20187965, PMID 40268883, PMID 40742572
D43DE032294 (1)